Dieses Forum nutzt Cookies
Dieses Forum verwendet Cookies, um deine Login-Informationen zu speichern, wenn du registriert bist, und deinen letzten Besuch, wenn du es nicht bist. Cookies sind kleine Textdokumente, die auf deinem Computer gespeichert sind; Die von diesem Forum gesetzten Cookies düfen nur auf dieser Website verwendet werden und stellen kein Sicherheitsrisiko dar. Cookies auf diesem Forum speichern auch die spezifischen Themen, die du gelesen hast und wann du zum letzten Mal gelesen hast. Bitte bestätige, ob du diese Cookies akzeptierst oder ablehnst.

Ein Cookie wird in deinem Browser unabhängig von der Wahl gespeichert, um zu verhindern, dass dir diese Frage erneut gestellt wird. Du kannst deine Cookie-Einstellungen jederzeit über den Link in der Fußzeile ändern.

Albemarle
WKN:ALB
#1
Notiz 

Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.
Quelle

Albemarle cuts 2019 guidance on lithium price weakness

Albemarle (NYSE:ALB) -7.1% after-hours in reaction to reducing guidance for full-year earnings and revenues due to continuing pressure from low lithium prices.
ALB now sees FY 2019 EPS of $6.00-$6.20, below prior guidance of $6.25-$6.65 and $6.28 analyst consensus, on revenues of $3.6B-$3.7B, slightly off its previous outlook of $3.65B-$3.85B but in line with $3.64 consensus.
While the company expects slight upside in its bromine and catalysts units in Q4, it will not offset weakness in lithium.
ALB also reports preliminary Q3 adjusted EPS of $1.53, below $1.62 consensus, with the lithium business expected to deliver revenue of $330M, up 22% Y/Y but lower than forecast primarily due to Typhoon Tapah, which caused shipments from ports in Shanghai to be delayed into October.
The company also says it expects FY 2020 EBITDA performance to be lower than 2019 results.

Quelle


[Bild: chart.ashx?t=ALB&ty=c&ta=1&p=d&s=l]

Hab kein Thema zu ALB gefunden

__________________
  Dein Geld ist nicht weg, es hat nur jemand anders. 
Interactive Brokers
Die Charts in meinen Beiträgen stammen von Seeking Alpha
#2
Notiz 

RE: Albemarle

ALBEMARLE (ALB) wurde am 23. April von S&P abgewertet auf BBB-   .... ... am Kliff zum Ramschniveau.  Scared

"The downgrade follows a significant downward revision in our macroeconomic expectations for 2020 because of the coronavirus pandemic. 

We now expect U.S. and eurozone 2020 GDP to decline by 5.2% and 7.3%, respectively, and Asia-Pacific (APAC) GDP to increase by a mere 0.3%. 

If the virus is not contained, the macroeconomic impact could be much more severe than we're factoring in our 2020 assumptions. 

We expect the automotive market will be particularly hard hit, and project global sales will decline by about 15% in 2020 to less than 80 million units. 

Additionally, we believe the material drop in oil prices (we expect WTI prices of $25 per barrel in 2020) will significantly impact the company's catalyst business, which primarily serves the refining end market. This recession follows a period when debt levels were elevated following the 2019 acquisition of the 60% stake in Mineral Resources Ltd.'s Wodgina hard rock lithium mine in Western Australia."
(S&P site)

Es geht also gar nicht so sehr um das größere Lithium Geschäft (38% revenue) sondern um den Catalyst Anteil (30% revenue).


Gehe zu:


Benutzer, die gerade dieses Thema anschauen: 1 Gast/Gäste